CAMPBELL PROMISES ACTION ON EPI PEN PRICE GOUGING: "IF YOU'RE RIPPING OFF SICK KIDS TO GET RICH YOU SHOULD BE IN JAIL."
BATON ROUGE -- Foster Campbell promised to lead the way on increased regulation for drug makers as controversy of markups on the life-saving drug Epi Pen continue to swirl.
"I'm disgusted that a CEO is getting rich off a device that delivers one dollar worth of drugs, charging moms and families $600 for something that can save their child's life. The fact that Congress hasn’t done something about this is inexcusable."
The CEO of Mylan, the company that manufactures Epi Pen, made $18 million last year after her company increased the cost of the drug that aids with the stop of life threatening allergic reactions by 461%.
“For me it’s simple. If you’re ripping off sick kids to get rich you should be in jail."
Campbell said he’d consider everything from removing patents on life saving medication to legislation updating the criminal code to address CEO abuses and the overarching problem of prescription price gouging.
Campbell called for immediate action including:
- A full investigation into price gouging across the market including hearings before the Senate Judiciary Committee
- Revocation of Mylan’s patent to allow generic manufacturers into the marketplace
- Refunds to insurance companies and consumers by Mylan in the amount of the increased cost of the Epi Pen over the last two years (around $300 per pen)
“This drug should cost $4. The only reason it costs hundreds is to make some CEO rich. And that's the truth. We've got to protect our families and kids, and I won’t stop till we fix this.”
Campbell’s said his record of taking on big special interests, and winning, has prepared him to see the fight against Mylan and other manufacturers through to the finish, “I sleep just fine at night taking on Wall Street crooks. I’ve been doing it all my life.”